Atara Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Atara Biotherapeutics Inc: Is Infosys Ltd. worth buying?
Item: Atara Biotherapeutics Inc
Rating: 1.64741675
Author: Trendlyne DVM scores

about

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and man...

5.50 -0.06 (-1.08%)

New 52W Low in past week

192.5K

XNAS Volume

XNAS 28 Jan, 2026 4:30 PM (EST)

Not Eligible

Mid Valuation

45.7 / 100

Technically Bearish

20.2 / 100

1Yr Price target upside is 58%

3 analysts

Atara Biotherapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Atara Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and man...

New 52W Low in past week

SWOT Analysis

Atara Biotherapeutics Inc Live Price Chart